141 – 160 of 211
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
-
Mark
Feasibility Study on Measuring Selected Proteins in Malignant Melanoma Tissue by SRM Quantification.
(
- Contribution to journal › Article
-
Mark
Plasma alkylresorcinol metabolites as biomarkers for whole-grain intake and their association with prostate cancer: a Swedish nested case-control study.
(
- Contribution to journal › Article
-
Mark
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
(
- Contribution to journal › Article
-
Mark
Investigation of a putative melanoma susceptibility locus at chromosome 3q29.
(
- Contribution to journal › Article
-
Mark
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study
(
- Contribution to journal › Letter
-
Mark
Svensk medicinsk forskning behöver inte mer styrning
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Organ Specific Killing af a Dispensable Organ or a Cell Population in an Organ - a Successful Design for Cancer Therapy - a Hypothesis
(
- Contribution to journal › Article
- 2013
-
Mark
Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer.
(
- Contribution to journal › Article
-
Mark
A variant in FTO shows association with melanoma risk not due to BMI
(
- Contribution to journal › Article
-
Mark
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
(
- Contribution to journal › Article
-
Mark
Prognostic factors in lung cancer in a defined geographical area over two decades with a special emphasis on gender.
(
- Contribution to journal › Article
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
(
- Contribution to journal › Article
-
Mark
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
(
- Contribution to journal › Article
-
Mark
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
(
- Contribution to journal › Article
- 2012
-
Mark
Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.
(
- Contribution to journal › Article
-
Mark
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study.
(
- Contribution to journal › Article
-
Mark
Metal-on-metal joint bearings and hematopoetic malignancy A review
(
- Contribution to journal › Scientific review
-
Mark
A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
(
- Contribution to journal › Article